Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 3 3Phase 2 3Phase 1/2 2Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1Phase 1 1

Status

Recruiting 30Completed 24Active not recruiting 17Terminated 10Not yet recruiting 7Withdrawn 3Unknown 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1

Conditions

Organoids 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Bone Cysts 1

Interventions

pembrolizumab 61Radiotherapy 55Gemcitabine 51Paclitaxel 49Cyclophosphamide 48Cisplatin 48Carboplatin 45Dexamethasone 37Bevacizumab 37Nivolumab 35Fluorouracil 34Docetaxel 34Oxaliplatin 33durvalumab 32Rituximab 28Magnetic Resonance Spectroscopy 28Leucovorin 28Drug Therapy 25Pemetrexed 24Doxorubicin 24Capecitabine 24atezolizumab 22Radiation 20Cytarabine 20Radiosurgery 19Prednisone 19Etoposide 19Irinotecan 17Bortezomib 17Cetuximab 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Withdrawn × Standard of Care × Clear all
NCT05378048 2023-03-29

Patient-derived-organoid (PDO) Guided Versus Conventional Therapy for Advanced Inoperable Abdominal Tumors

Chinese University of Hong Kong

Phase 2 Withdrawn

Organoids

NCT03628144 2020-09-10

Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00459641 2012-07-17

Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts

Kuros Biosurgery AG

Phase 2 Withdrawn

Bone Cysts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡